Public Profile

Emergent BioSolutions

Emergent BioSolutions Inc., a leading biopharmaceutical company headquartered in the United States, specialises in developing and manufacturing vaccines and therapeutics for public health threats. Founded in 1998, the company has achieved significant milestones, including the acquisition of key assets that bolster its position in the biodefence and infectious disease sectors. With a strong operational presence across North America and Europe, Emergent BioSolutions focuses on core products such as vaccines for anthrax and smallpox, as well as treatments for opioid overdose. What sets the company apart is its commitment to addressing urgent health needs through innovative solutions and strategic partnerships. Recognised for its expertise in biodefence, Emergent BioSolutions continues to play a pivotal role in enhancing global health security.

DitchCarbon Score

How does Emergent BioSolutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

31

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

24

Industry Benchmark

Emergent BioSolutions's score of 31 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

90%

Emergent BioSolutions's reported carbon emissions

In 2023, Emergent BioSolutions reported total carbon emissions of approximately 16,856,000 kg CO2e from Scope 1 and 18,436,000 kg CO2e from Scope 2, resulting in a combined total of about 35,292,000 kg CO2e. This marks a reduction from 2022, where the company emitted approximately 19,334,000 kg CO2e in Scope 1 and 21,099,000 kg CO2e in Scope 2, totalling around 40,434,000 kg CO2e. Emergent BioSolutions has disclosed emissions data for both Scope 1 and Scope 2, but has not provided information on Scope 3 emissions. The company has not set specific reduction targets or initiatives as part of its climate commitments. The emissions intensity per full-time equivalent employee was reported at approximately 13,900 kg CO2e in 2023, slightly higher than the 13,600 kg CO2e reported in 2022. This indicates a need for further efforts to enhance sustainability practices and reduce overall carbon footprint.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20222023
Scope 1
19,334,000
00,000,000
Scope 2
21,099,000
00,000,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Emergent BioSolutions's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Emergent BioSolutions is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Emergent BioSolutions is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Sanofi

FR
Chemicals nec
Updated about 14 hours ago

Phastar

GB
Other services (93)
Updated about 20 hours ago

Kedrion

IT
Research and development services (73)
Updated 4 days ago

Achillion Pharmaceuticals, Inc.

US
Health and social work services (85)
Updated 25 days ago
DitchCarbon Score

Hikma Pharmaceuticals

GB
Health and social work services (85)
Updated 4 days ago

Thermo Fisher Scientific

US
Chemicals nec
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers